Image-guided drug delivery: preclinical applications and clinical translation
- 17 June 2015
- journal article
- Published by Informa Healthcare in Expert Opinion on Drug Delivery
- Vol. 12 (8) , 1203-1207
Abstract
Image-guided drug delivery refers to the combination of drug targeting and imaging. Preclinically, image-guided drug delivery can be used for several different purposes, including for monitoring biodistribution, target site accumulation, off-target localization, drug release and drug efficacy. Clinically, it holds significant potential for preselecting patients. In this editorial, we briefly summarize the main principles of image-guided drug delivery, and we describe its potential for facilitating, furthering and personalizing nanomedicine treatments.Keywords
This publication has 14 references indexed in Scilit:
- Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applicationsCurrent Opinion in Biotechnology, 2013
- Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in OncologyCancer Research, 2013
- Noninvasive Optical Imaging of Nanomedicine BiodistributionACS Nano, 2012
- Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progressJournal of Controlled Release, 2012
- Hyperthermia-triggered drug delivery from temperature-sensitive liposomes using MRI-guided high intensity focused ultrasoundJournal of Controlled Release, 2012
- The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effectAdvanced Drug Delivery Reviews, 2011
- Impact of Nanotechnology on Drug DeliveryACS Nano, 2009
- Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancerAnnals of Oncology, 2004
- High Intratumoral Accumulation of Stealth Liposomal Doxorubicin in Sarcomas: Rationale for Combination with RadiotherapyActa Oncologica, 2000
- Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.Journal of Clinical Oncology, 1998